(Q54517330)
Statements
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. (English)
S K Metzelder
T Schroeder
A Finck
S Scholl
M Fey
K Götze
Y C Linn
M Kröger
A Reiter
H R Salih
T Heinicke
R Stuhlmann
L Müller
A Giagounidis
R G Meyer
W Brugger
M Vöhringer
P Dreger
M Mori
N Basara
K Schäfer-Eckart
B Schultheis
C Baldus
A Neubauer
A Burchert
16 April 2012
26
11
2353-2359
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference